NDC 55150-443

regadenoson

Regadenoson

regadenoson is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Eugia Us Llc. The primary component is Regadenoson.

Product ID55150-443_b553eb2d-0c3f-444e-ad4c-282328683110
NDC55150-443
Product TypeHuman Prescription Drug
Proprietary Nameregadenoson
Generic NameRegadenoson
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-10-26
Marketing CategoryANDA /
Application NumberANDA216437
Labeler NameEugia US LLC
Substance NameREGADENOSON
Active Ingredient Strength0 mg/mL
Pharm ClassesAdenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 55150-443-01

1 SYRINGE in 1 CARTON (55150-443-01) > 5 mL in 1 SYRINGE
Marketing Start Date2022-10-26
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "regadenoson" or generic name "Regadenoson"

NDCBrand NameGeneric Name
55150-443regadenosonregadenoson
68083-175RegadenosonRegadenoson
71288-201RegadenosonRegadenoson
0469-6501LEXISCANregadenoson

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.